Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson ’s Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway

Conclusion: GLB suppresses LPS-induced PD symptoms by modification of TLR/NF- κB and Nrf2/HO-1 pathwaysin vivo andin vitro.Cell Physiol Biochem 2017;44:2091 –2104

https://www.karger.com/Article/FullText/485947

Source: Cellular Physiology and Biochemistry - December 14, 2017 Category: Cytology Source Type: research